Metformin and Combined Oral Contraceptive Pills in the Management of Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis.

ABSTRACT:

Context

Polycystic ovary syndrome (PCOS) affects more than 1 in 10 women.

Objective

As part of the 2023 International PCOS Guidelines update, comparisons between combined oral contraceptive pills (COCP), metformin, and combination treatment were evaluated.

Data sources

Ovid Medline, Embase, PsycINFO, All EBM, and CINAHL were searched.

Study selection

Women with PCOS included in randomized controlled trials (RCTs).

Data extraction

We calculated mean differences and 95% CIs regarding anthropometrics, metabolic, and hyperandrogenic outcomes. Meta-analyses and quality assessment using GRADE were performed.

Data synthesis

The search identified 1660 publications; 36 RCTs were included. For hirsutism, no differences were seen when comparing metformin vs

SUBMITTER: Melin J 

PROVIDER: S-EPMC10795934 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature